Delivery Order SPE2DR25D2208-SPE2DR26FB4VV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,641.52 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts on November 13, 2025, with completion expected by November 14, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,014.03 to AmerisourceBergen Drug Corp for Yuvafem 10 microgram vaginal inserts (18-count). The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. Performance will occur at the contractor's Conshohocken, Pennsylvania facility, with an ultimate completion date of November 12, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $1,616.29 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count package) on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $1,145.73 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on August 13, 2025, with completion scheduled for August 14, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, procured through open competition. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) under a firm fixed-price contract valued at $1,294.26. The order was competitively awarded without set-aside designation and is scheduled for completion by August 1, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and supply this pharmaceutical product to support federal medical...
- The Defense Logistics Agency awarded a $30,704.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 microgram vaginal inserts (18-count) on October 22, 2025, with completion scheduled for October 23, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $1,233.95 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg Vaginal Insert (8 count) on January 16, 2026, with completion scheduled for January 20, 2026. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is a child transaction under AmerisourceBergen's...
- The Defense Logistics Agency has awarded a delivery order valued at $1,286.04 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 microgram vaginal inserts (18-count). This is a firm fixed price delivery order with no set-aside designation, awarded competitively on November 26, 2025, with an ultimate completion date of November 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,702.11 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (8-count packages) on December 22, 2025, with a completion date of December 23, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a $1,357.95 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 MCG vaginal insert (18-pack) on December 17, 2025, with completion targeted for December 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DR25D2208Indefinite Delivery Contract
- SPE2DR25D2208-SPE2DR26FB4VVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,294.29 to AmerisourceBergen Drug Corp for Yuvafem 10 microgram vaginal inserts (8-count package) on January 20, 2026, with an ultimate completion date of January 21, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award vehicle valued at up to $999,999,999.00 through December 2031 that provides comprehensive pharmaceutical and medical supply support to military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, regularly supplies medications and medical supplies across multiple therapeutic domains to support Department of Defense and military treatment facilities worldwide. The Yuvafem product is a hormone treatment used in medical care, consistent with the company's extensive portfolio of brand-name and generic pharmaceuticals, vaccines, and specialized medical supplies that it delivers through its DLA contract vehicles. This delivery order exemplifies the routine procurement of essential pharmaceutical commodities that support military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 1/19/26 |